We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX 30, "Evotec") announced today that the first milestone has been achieved in its four-year drug discovery collaboration with Takeda Pharmaceutical Company Limited (Osaka, Japan, "Takeda").
South Africa's Department of Health is planning to pass legislation
allowing traditional healers in the country to claim fees from medical aid schemes.
Europe must take action in order to stop its pharmaceuticals industry from falling behind the US, according to claims made by the British government as it holds the rotating presidency of the European Union (EU).
Applied Biosystems Group (NYSE:ABI), an Applera Corporation business and QIAGEN N.V. (NASDAQ:QGEN)(Frankfurt, Prime Standard:QIA) today announced that they have entered into a license agreement.
Auckland biotechnology company Neuren Pharmaceuticals plans to use A$6.4 million ($6.81 million) raised from a share placement for drug trial programmes.
French pharmaceutical company Sanofi-Aventis (SNY) (SNY) Friday specified it will inject up to EUR51 million for the expansion of its Frankfurt production site.
Schering AG said it is considering selling its CIS bio International SA radiopharmaceutical business and that such a sale would have a negative one-time effect on results.